Biogen Inc (NASDAQ:BIIB)
| 283.65 Delayed Data As of 3:59pm ET |  -3.69 / -1.29%Today’s Change | 187.16 Today|||52-Week Range 311.88 | +2.43% Year-to-Date |
Latest BIIB News | Press Releases
Today’s Trading
| Previous close | 287.34 |
| Today’s open | 290.06 |
| Day’s range | 282.52 - 291.00 |
| Volume | 41,771 |
| Average volume (3 months) | 1,558,558 |
| Market cap | $41.8B |
Data as of 3:59pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | -58.03% |
| Earnings growth (this year) | -10.89% |
| Earnings growth (next 5 years) | -1.70% |
| Revenue growth (last year) | -15.81% |
| P/E ratio | 14.5 |
| Price/Sales | 3.45 |
| Price/Book | 3.91 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | -10.56 | -4.69% |
| BMRNBiomarin Pharmaceuti... | -0.59 | -0.52% |
| ---- | ||
| MRNAModerna Inc | -3.03 | -1.72% |
Data as of 4:00pm ET, 02/03/2023
Financials
| Next reporting date | February 15, 2023 |
| EPS forecast (this quarter) | $3.51 |
| Annual revenue (last year) | $10.4B |
| Annual profit (last year) | $1.6B |
| Net profit margin | 14.96% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
